Search Results

There are 32985 results for: content related to: Profiling two indole-2-carboxamides for allosteric modulation of the CB 1 receptor

  1. You have free access to this content
    Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease

    Journal of Neurochemistry

    Volume 129, Issue 1, April 2014, Pages: 4–20, Claire J. Williams and David T. Dexter

    Version of Record online : 2 DEC 2013, DOI: 10.1111/jnc.12608

  2. You have free access to this content
    Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites

    British Journal of Pharmacology

    Volume 172, Issue 1, January 2015, Pages: 93–105, Xiang-Qun Hu

    Version of Record online : 24 NOV 2014, DOI: 10.1111/bph.12896

  3. Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor

    Medicinal Research Reviews

    Volume 37, Issue 3, May 2017, Pages: 441–474, Thuy Nguyen, Jun-Xu Li, Brian F. Thomas, Jenny L. Wiley, Terry P. Kenakin and Yanan Zhang

    Version of Record online : 23 NOV 2016, DOI: 10.1002/med.21418

  4. You have free access to this content
    Rational design of dualsteric GPCR ligands: quests and promise

    British Journal of Pharmacology

    Volume 159, Issue 5, March 2010, Pages: 997–1008, Klaus Mohr, Christian Tränkle, Evi Kostenis, Elisabetta Barocelli, Marco De Amici and Ulrike Holzgrabe

    Version of Record online : 5 FEB 2010, DOI: 10.1111/j.1476-5381.2009.00601.x

  5. Overview of Critical Parameters for the Design and Execution of a High-Throughput Screen for Allosteric Ligands

    Unit

    Current Protocols in Pharmacology

    9:9.20.1–9.20.23

    Andrew Alt

    Published Online : 16 SEP 2016, DOI: 10.1002/cpph.12

  6. You have full text access to this OnlineOpen article
    Functional interaction between Lypd6 and nicotinic acetylcholine receptors

    Journal of Neurochemistry

    Volume 138, Issue 6, September 2016, Pages: 806–820, Maria Arvaniti, Majbrit M. Jensen, Neeraj Soni, Hong Wang, Anders B. Klein, Nathalie Thiriet, Lars H. Pinborg, Pretal P. Muldoon, Jacob Wienecke, M. Imad Damaj, Kristi A. Kohlmeier, Marjorie C. Gondré-Lewis, Jens D. Mikkelsen and Morten S. Thomsen

    Version of Record online : 15 AUG 2016, DOI: 10.1111/jnc.13718

  7. You have full text access to this OnlineOpen article
    A nicotinic acetylcholine receptor transmembrane point mutation (G275E) associated with resistance to spinosad in Frankliniella occidentalis

    Journal of Neurochemistry

    Volume 124, Issue 5, March 2013, Pages: 590–601, Alin M. Puinean, Stuart J. Lansdell, Toby Collins, Pablo Bielza and Neil S. Millar

    Version of Record online : 13 JAN 2013, DOI: 10.1111/jnc.12029

  8. You have free access to this content
    Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

    British Journal of Pharmacology

    Volume 172, Issue 20, October 2015, Pages: 4790–4805, R B Laprairie, A M Bagher, M E M Kelly and E M Denovan-Wright

    Version of Record online : 13 OCT 2015, DOI: 10.1111/bph.13250

  9. You have free access to this content
    Real-time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action

    British Journal of Pharmacology

    Volume 170, Issue 4, October 2013, Pages: 893–907, Erin E Cawston, William J Redmond, Courtney M Breen, Natasha L Grimsey, Mark Connor and Michelle Glass

    Version of Record online : 1 OCT 2013, DOI: 10.1111/bph.12329

  10. Overview of Receptor Allosterism

    Unit

    Current Protocols in Pharmacology

    1:1.21.1–1.21.34

    Karen J. Gregory, Patrick M. Sexton and Arthur Christopoulos

    Published Online : 1 DEC 2010, DOI: 10.1002/0471141755.ph0121s51

  11. Molecular Alliance—From Orthosteric and Allosteric Ligands to Dualsteric/Bitopic Agonists at G Protein Coupled Receptors

    Angewandte Chemie International Edition

    Volume 52, Issue 2, January 7, 2013, Pages: 508–516, Prof. Dr. Klaus Mohr, Dr. Jens Schmitz, Ramona Schrage, Priv.-Doz. Christian Tränkle and Prof. Dr. Ulrike Holzgrabe

    Version of Record online : 6 DEC 2012, DOI: 10.1002/anie.201205315

  12. You have free access to this content
    Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications

    British Journal of Pharmacology

    Volume 172, Issue 2, January 2015, Pages: 277–286, N T Burford, J R Traynor and A Alt

    Version of Record online : 1 JUL 2014, DOI: 10.1111/bph.12599

  13. You have free access to this content
    MMP-9 in translation: from molecule to brain physiology, pathology, and therapy

    Journal of Neurochemistry

    Volume 139, Issue S2, October 2016, Pages: 91–114, Behnam Vafadari, Ahmad Salamian and Leszek Kaczmarek

    Version of Record online : 21 MAR 2016, DOI: 10.1111/jnc.13415

  14. You have free access to this content
    Investigating the interaction of McN-A-343 with the M1 muscarinic receptor using its nitrogen mustard derivative and ACh mustard

    British Journal of Pharmacology

    Volume 160, Issue 6, July 2010, Pages: 1534–1549, KW Figueroa, H Suga and FJ Ehlert

    Version of Record online : 26 APR 2010, DOI: 10.1111/j.1476-5381.2010.00810.x

  15. You have full text access to this OnlineOpen article
    Allosteric interactions at adenosine A1 and A3 receptors: new insights into the role of small molecules and receptor dimerization

    British Journal of Pharmacology

    Volume 171, Issue 5, March 2014, Pages: 1102–1113, Stephen J Hill, Lauren T May, Barrie Kellam and Jeanette Woolard

    Version of Record online : 27 FEB 2014, DOI: 10.1111/bph.12345

  16. You have free access to this content
    Molecular changes in the postmortem parkinsonian brain

    Journal of Neurochemistry

    Volume 139, Issue S1, October 2016, Pages: 27–58, Damien Toulorge, Anthony H. V. Schapira and Rodolphe Hajj

    Version of Record online : 5 JUL 2016, DOI: 10.1111/jnc.13696

  17. You have free access to this content
    Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor

    British Journal of Pharmacology

    Volume 171, Issue 23, December 2014, Pages: 5295–5312, Dong Guo, Suzanne N Venhorst, Arnault Massink, Jacobus P D van Veldhoven, Georges Vauquelin, Adriaan P IJzerman and Laura H Heitman

    Version of Record online : 5 SEP 2014, DOI: 10.1111/bph.12836

  18. You have free access to this content
    Characterization of [3H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand

    Journal of Neurochemistry

    Volume 131, Issue 4, November 2014, Pages: 418–431, Claudia Rangel-Barajas, Maninder Malik, Michelle Taylor, Kim A. Neve, Robert H. Mach and Robert R. Luedtke

    Version of Record online : 19 AUG 2014, DOI: 10.1111/jnc.12825

  19. You have free access to this content
    Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways

    Journal of Neurochemistry

    Volume 133, Issue 5, June 2015, Pages: 700–707, Rania M. Abdelsalam and Marwa M. Safar

    Version of Record online : 26 MAR 2015, DOI: 10.1111/jnc.13087

  20. Post-ischemic salubrinal treatment results in a neuroprotective role in global cerebral ischemia

    Journal of Neurochemistry

    Volume 138, Issue 2, July 2016, Pages: 295–306, Berta Anuncibay-Soto, Diego Pérez-Rodríguez, María Santos-Galdiano, Enrique Font, Marta Regueiro-Purriños and Arsenio Fernández-López

    Version of Record online : 16 MAY 2016, DOI: 10.1111/jnc.13651